AVTAR S DHILLON Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for AVTAR S DHILLON.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of AVTAR S DHILLON. AVTAR S DHILLON is Director in INOVIO PHARMACEUTICALS, INC. ($GEB) and President & CEO in INOVIO PHARMACEUTICALS, INC. ($GEB) and Director in Vitality Biopharma, Inc. ($STVF) and Director in ONCOSEC MEDICAL Inc ($ONCS.D) and Director in Nemus Bioscience, Inc. ($NMUS) and Director in Arch Therapeutics, Inc. ($ARTH).

Over the past year AVTAR S DHILLON has been an insider in 1 company. The total value of shares held by AVTAR S DHILLON in this company amounts to $71,360.

AVTAR S DHILLON Director
Arch Therapeutics, Inc.
Director, President & CEO
INOVIO PHARMACEUTICALS, INC.
Director
ONCOSEC MEDICAL Inc
Director
Skye Bioscience, Inc.
Director
Vitality Biopharma, Inc.
$ 71360 The total value of shares held by AVTAR S DHILLON
Insider Rank

AVTAR S DHILLON ranks 30,922 out of 350,000 insiders. Go to Insider Ranking to see more.

Latest Insider Trading Transactions of AVTAR S DHILLON

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000022
Value of Purchases ($)0000038,75038,750
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARTH, GEB, ONCS, NMUS, VBIO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 21 2020ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorGrantA1.5512,50019,37562,05249.6 K to 62.1 K (+25.23 %)
Apr 21 2020ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorGrantA1.5512,50019,37562,05249.6 K to 62.1 K (+25.23 %)
Jan 04 2019ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseA0.6650,00032,75050,000
Dec 06 2018GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseM2.0025,00050,0000
Dec 06 2018GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorBuyM2.0025,00050,000106,00281 K to 106 K (+30.86 %)
Oct 12 2018NMUSNemus Bioscience, ...DHILLON AVTAR SDirectorOption ExerciseA0.311,000,000305,0001,000,000
Jul 20 2018ARTHArch Therapeutics, ...DHILLON AVTAR SDirectorOption ExerciseA0.43220,00093,500220,000
Jul 20 2018ARTHArch Therapeutics, ...DHILLON AVTAR SDirectorGrantA0.00220,00008,517,3738.3 M to 8.5 M (+2.65 %)
Jul 06 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseM0.00100,00000
Jul 06 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorSellS1.313,1004,067143,427146.5 K to 143.4 K (-2.12 %)
Jul 06 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorSellS1.381,0661,471146,527147.6 K to 146.5 K (-0.72 %)
Jul 06 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorSellS1.401,5562,180147,593149.1 K to 147.6 K (-1.04 %)
Jul 06 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorSellS1.373,4514,742149,149152.6 K to 149.1 K (-2.26 %)
Jul 06 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorSellS1.404,7036,575152,600157.3 K to 152.6 K (-2.99 %)
Jul 06 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorSellS1.41202284157,303157.5 K to 157.3 K (-0.13 %)
Jul 06 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorSellS1.422,9564,192157,505160.5 K to 157.5 K (-1.84 %)
Jul 06 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorSellS1.402,1783,051160,461162.6 K to 160.5 K (-1.34 %)
Jul 06 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorSellS1.4210,97315,604162,639173.6 K to 162.6 K (-6.32 %)
Jul 06 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorSellS1.361,8382,507173,612175.5 K to 173.6 K (-1.05 %)
Jul 06 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorSellS1.395,5527,695175,450181 K to 175.5 K (-3.07 %)
Jul 06 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorBuyM0.00100,0000181,00281 K to 181 K (+123.45 %)
May 14 2018GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseM0.007,66900
May 14 2018GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA0.008,17008,170
May 14 2018GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA4.5612,50057,00012,500
May 14 2018GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorBuyM0.007,669081,00273.3 K to 81 K (+10.46 %)
Feb 09 2018ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseA1.64350,000574,000647,916
May 15 2017GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseM0.0010,00000
May 15 2017GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA7.1412,50089,25012,500
May 15 2017GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA0.007,66907,669
May 15 2017GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorBuyM0.0010,000073,33363.3 K to 73.3 K (+15.79 %)
Mar 31 2017ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseA1.3420,00026,800297,916
Feb 06 2017ARTHArch Therapeutics, ...DHILLON AVTAR SDirectorOption ExerciseA0.65400,000260,000400,000
Feb 06 2017ARTHArch Therapeutics, ...DHILLON AVTAR SDirectorGrantA0.00400,00008,297,3737.9 M to 8.3 M (+5.06 %)
Dec 16 2016ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseA1.29265,416342,387265,416
Dec 16 2016ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseD5.76500,0002,880,0000
Dec 16 2016ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseD7.6012,50095,0000
Dec 16 2016ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseD16.1012,500201,2500
Dec 16 2016ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseD5.005,00025,0000
Dec 16 2016ONCSONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseD4.205,00021,0000
Aug 17 2016STVFVitality Biopharma ...DHILLON AVTAR SDirectorOption ExerciseA0.00925,58501,015,585
Aug 17 2016STVFVitality Biopharma ...DHILLON AVTAR SDirectorOption ExerciseA2.1040,00084,00090,000
May 16 2016GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA9.3310,00093,30010,000
May 16 2016GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA0.0010,000010,000
May 09 2016GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseM0.005,00000
May 09 2016GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorBuyM0.005,000063,33358.3 K to 63.3 K (+8.57 %)
May 05 2016ARTHArch Therapeutics, ...DHILLON AVTAR SDirectorOption ExerciseA0.39830,000323,700830,000
May 05 2016ARTHArch Therapeutics, ...DHILLON AVTAR SDirectorGrantA0.00737,00007,897,3737.2 M to 7.9 M (+10.29 %)
Mar 08 2016ONCS.DONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseA0.00100,0000100,000
Mar 08 2016ONCS.DONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseA2.0212,50025,250547,500
Oct 19 2015ONCS.DONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorBuyP4.3610,00043,59010,0000 to 10 K
Aug 24 2015ONCS.DONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseA5.67500,0002,835,000500,000
Aug 19 2015ARTHArch Therapeutics, ...DHILLON AVTAR SDirectorOption ExerciseA0.28355,00099,400355,000
May 08 2015GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA8.017,50060,0757,500
May 08 2015GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA0.005,00005,000
Mar 04 2015ONCS.DONCOSEC MEDICAL In ...DHILLON AVTAR SDirectorOption ExerciseA0.37250,00092,500250,000
Jan 19 2005GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SPresident & CEOOption ExerciseA3.82150,000573,000150,000
Oct 14 2004GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SPresident & CEOBuyP2.566,60016,89660,18753.6 K to 60.2 K (+12.32 %)
Oct 14 2004GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SPresident & CEOBuyP2.554001,02053,58753.2 K to 53.6 K (+0.75 %)
Oct 14 2004GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SPresident & CEOBuyP2.443,0007,32053,18750.2 K to 53.2 K (+5.98 %)
Sep 15 2004GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SPresident & CEOOption ExerciseP8.801,0299,0551,029
Sep 15 2004GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SPresident & CEOBuyP11,764.70223,52920 to 2

Page:   1